# CORRESP — Bionano Genomics, Inc.  (BNGO)  (CIK 0001411690)

> <strong>Bionano Genomics, Inc.  (BNGO)  (CIK 0001411690) → SEC staff</strong> · filed 2025-09-11 · ticker BNGO · SIC 3826

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001140361-25-034703
- **Form:** CORRESP
- **Filer:** Bionano Genomics, Inc.  (BNGO)  (CIK 0001411690)
- **CIK:** 0001411690
- **Ticker:** BNGO
- **Filed:** 2025-09-11
- **SIC industry:** 3826
- **HQ:** San Diego, CA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1411690/000114036125034703/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1411690&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Bionano Genomics, Inc.  (BNGO)  (CIK 0001411690)

- CORRESP — 2025-09-11 — /comment-letter/0001140361-25-034704

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Bionano Genomics, Inc.  (BNGO)  (CIK 0001411690) (CIK 0001411690), filed 2025-09-11, accession 0001140361-25-034703. Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/comment-letter/0001140361-25-034703.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*